Flu season ends with a whisper, not a bang.

Published Date: 14 Mar 2023

The 2022-2023 flu season is on the edge of life which has been predicted for half of January and most of February.

Read Full News

Latest News

Growing Shortage of Pediatric Healthcare Workforce

A profound shortage of pediatric healthcare professionals threatens children's health.

Precompetition Abstinence: Evidence Challenges Myth

Published findings suggest clinicians should avoid blanket abstinence and offer individualized, stigma-free guidance on sleep and recovery for competitive athletes.

Longer Colonoscopy Time May Improve Flat Adenoma Detection

Examining the proximal colon for 3 minutes or longer during screening colonoscopy may improve detection of flat adenomas.

How Nanotech Made an Old Leukemia Drug 22,000x Stronger

Structural nanomedicine — what helped give us the COVID vaccine — may now be the key to a potent blood cancer treatment that’s had remarkable early results.

Medium-Chain Triglycerides Can Improve Quality of Life in RA

Incorporating medium-chain triglycerides into the regular diet of patients with rheumatoid arthritis can improve their mental well-being and social functioning, a 16-week randomized trial shows.

Zongertinib Picks Up First-Line Metastatic NSCLC Indication

The accelerated approval for patients with HER2 (ERBB2)-mutated disease follows an approval last August for use after prior systemic therapy.

Todays Updates

Immunotherapy Remains Little Used in Head and Neck Cancer

Immune checkpoint inhibitors have been FDA-approved for head and neck cancer for a decade, but their use has only marginally increased among patients younger than 65.

EVP Beats Cisplatin for Resectable MIBC

As the first chemotherapy-free regimen to beat gemcitabine/cisplatin, perioperative enfortumab vedotin plus pembrolizumab could shift muscle-invasive bladder cancer care — but questions remain.

Belzutifan Combo Could be Second-Line Option in Advanced RCC

Belzutifan plus lenvatinib significantly improves outcomes vs single agent cabozantinib in patients with advanced RCC who progressed after anti-PD-(L)1 therapy, new data show.

Todays Updates

Immunotherapy Remains Little Used in Head and Neck Cancer

Immune checkpoint inhibitors have been FDA-approved for head and neck cancer for a decade, but their use has only marginally increased among patients younger than 65.

EVP Beats Cisplatin for Resectable MIBC

As the first chemotherapy-free regimen to beat gemcitabine/cisplatin, perioperative enfortumab vedotin plus pembrolizumab could shift muscle-invasive bladder cancer care — but questions remain.

Belzutifan Combo Could be Second-Line Option in Advanced RCC

Belzutifan plus lenvatinib significantly improves outcomes vs single agent cabozantinib in patients with advanced RCC who progressed after anti-PD-(L)1 therapy, new data show.

Latest News

A profound shortage of pediatric healthcare professionals threatens children's health.

Published findings suggest clinicians should avoid blanket abstinence and offer individualized, stigma-free guidance on sleep and recovery for competitive athletes.

Examining the proximal colon for 3 minutes or longer during screening colonoscopy may improve detection of flat adenomas.

Structural nanomedicine — what helped give us the COVID vaccine — may now be the key to a potent blood cancer treatment that’s had remarkable early results.

Incorporating medium-chain triglycerides into the regular diet of patients with rheumatoid arthritis can improve their mental well-being and social functioning, a 16-week randomized trial shows.

The accelerated approval for patients with HER2 (ERBB2)-mutated disease follows an approval last August for use after prior systemic therapy.

News All Time

SNNOOP10 to Screen for Primary vs Secondary Headaches

Dr Nina Lum discusses the SNNOOP10 mnemonic for screening for primary vs secondary headaches.

Infographic: Foreign-Trained Docs Help With Shortage Here

Strong majorities of physicians in the US think doctors trained in other countries receive solid schooling and training and could help with shortages here.

Episode 3: Primary Aldosteronism and Secondary Hypertension

Drs Marwah Abdalla and Vivek Bhalla discuss the screening, management, and future of primary aldosteronism -- a common cause of secondary hypertension.

Managing Chronic Hepatitis B: New Guideline Expands Options

Joint AASLD/IDSA practice recommendations reflect new data on prevention, treatment, and surveillance of chronic hepatitis B, emphasizing collaborative decision-making.

Treating Cancer by Molecular Footprint, Not Organ

Shifting the focus from organ to biomarker has unlocked new options for rare and advanced cancers. Uneven efficacy, diagnostic access, and regulation still slow clinical rollout.

Risk-Reducing Mastectomy in BRCA1/2: Does It Save Lives?

Two recent studies aim to clarify whether risk-reducing bilateral mastectomy among BRCA1/2 carriers can improve survival, but the findings underscore the limits of the current evidence.

Galleri Cancer Detection Test Fails in Key Trial: Now What?

Despite efforts by test maker Grail to highlight outcomes the company considers positive, some experts are warning against using the Galleri test and others like it.

New Deprescribing Guidance Marks ‘Important Moment’ in Psych

A new consensus statement from the American Society of Clinical Psychopharmacology offers guidance on when — and whether — to discontinue psychotropic medications.

CKD Linked to Higher Risk for Workforce Detachment

Chronic kidney disease is associated with a significantly increased risk for workforce detachment among adults of working age, a Danish study finds.

Residents With Children Are at a Financial Breaking Point

As childcare costs soar and pay lags behind inflation, residents are forced into impossible choices about family and training.

Maternity Services ‘Still Failing’ Women and Babies

An interim review finds discrimination, staffing gaps, and poor facilities continue to undermine NHS maternity care in England.

Hospitals Face Measles Challenge: Few Doctors Have Seen It

As the US hospitals face an increasing risk of encountering measles, healthcare workers face an unusual barrier: Many don’t know what it looks like.

Blood Test Predicts Timing of Alzheimer’s Onset

Plasma p-tau217 levels predict the timing of Alzheimer’s onset in cognitively unimpaired adults in the research that could potentially guide research and preventive trials.

Higher Genetic Risk for IBD Linked to Disease Severity

Higher genetic risk for inflammatory bowel disease is linked to more severe disease and increased risks for hospital stays and earlier need for advanced treatments.

MDMA Analogue Shows Rapid, Durable Benefit in PTSD

A novel, non-hallucinogenic, experimental drug shows statistically significant, rapid, and durable improvement in PTSD symptom severity in a phase 2 trial.

Recommended News For You

Healthcare in the Mix in President Biden's Farewell Address

Prostate cancer death risk is higher in late teens and early 20s weight gain.

Why preventive mastectomy isn't offered to everyone at risk

Life quality after childhood cancer is quantifiable thanks to outcome indicators.

The Truth About Apple AirPods

Children with the "Failure to Launch" Syndrome in Adulthood Have New Hope.

Could AI plus lasers help catch very early breast cancers?

Recommended Articles For You

What You Need to Know about Hairy Cell Leukemia: A Comprehensive Guide  

Personalized Cancer Vaccines and Neoantigen mRNA: A New Era in Oncology 

Multidisciplinary Insights into Diagnosis, Management, and Outcomes in Oncology 

Next-Gen CAR Cell Therapies in Oncology: Frontiers in Solid Tumors & Hematologic Malignancies 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Alkem introduces cetuximab under the trade name Cetuxa in India.

2.

When BCG is not effective in treating bladder cancer, Oncolytic Virus exhibits high response rates.

3.

FDA-approved FGFR inhibitors show promise against rare and aggressive pediatric brain tumor

4.

Nearly 4 million lung cancer deaths averted and 76 million years of life gained due to tobacco control in US

5.

Antitumor mRNA-based vaccines show potential against gastric cancer metastasis

1.

A Closer Look at Poorly Differentiated Carcinoma: Uncovering its Complexities

2.

Mastering Breast Cancer Care in 2025: Diagnosis, Treatment, Education, and Innovation

3.

New Research on Craniopharyngioma 

4.

Nuclear Medicine's Role in Battling Women's Cancers

5.

Lu-177 Vipivotide in Prostate Cancer: A Breakthrough in Radioligand Therapy

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Redefining Treatment Pathways in Relapsed/Refractory Adult B-Cell ALL

2.

Efficient Management of First line ALK-rearranged NSCLC

3.

Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation

4.

EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion

5.

Learning About Different Treatment Approaches For Acute Lymphoblastic Leukemia

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot